Natera, Inc. Announces Fourth Quarter and Fiscal 2018 Earnings Conference Call

Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA, today announced that it will release results for its fourth quarter and year ended December 31, 2018, after the market close on March 12, 2019.

SAN CARLOS, Calif., /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA, today announced that it will release results for its fourth quarter and year ended December 31, 2018, after the market close on March 12, 2019. Natera will host a conference call and webcast at 4 p.m. ET (1 p.m. PT) to discuss its financial results, business activities, and financial outlook.

Natera, Inc. Logo (PRNewsFoto/Natera, Inc.)

Natera CEO Steve Chapman is also scheduled to present at the 39th Annual Cowen Healthcare Conference in Boston on March 13, 2019, at 11:20 a.m. ET (8:20 a.m. PT).

Earnings Conference Call Information:

Event:

Natera’s Fourth Quarter and Year-End 2018 Financial Results

Date:

Tuesday, March 12, 2019

Time:

4 p.m. ET (1 p.m. PT)

Live Dial-In:

(877) 823-0171, Domestic

(617) 500-6932, International

Conference ID:

7292809

Webcast:

https://edge.media-server.com/m6/p/9m89tec8

A webcast replay will be available at investor.natera.com.

Cowen Healthcare Conference Details:

Event:

39th Annual Cowen Healthcare Conference

Date:

Wednesday, March 13, 2019

Time:

11:20 a.m. ET (8:20 a.m. PT)

Live Webcast:

Interested parties can access the live webcast with accompanying slides at http://wsw.com/webcast/cowen52/ntra/.

The webcast replay will be available one hour after the conclusion of the live presentation and archived for 90 days.

About Natera
Natera is a global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, researchers in cancer including bio pharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn and Twitter.

Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 650-249-9090
Media: Andrea Sampson, Sullivan & Sampson, 714-374-6174, asampson@sullivanpr.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-inc-announces-fourth-quarter-and-fiscal-2018-earnings-conference-call-300807071.html

SOURCE Natera, Inc.


Company Codes: NASDAQ-NMS:NTRA
MORE ON THIS TOPIC